Cytoskeletal dependence of adenosine triphosphate release by human trabecular meshwork cells

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 11, 2011, Pages 7996-8005

  Li, Ang ^a   Leung, Chi Ting ^a   Peterson Yantorno, Kim ^a   Daniel Stamer, W ^b   Civan, Mortimer M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIN; ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE; CYTOCHALASIN D; DEXAMETHASONE; GELATINASE A; GELATINASE B; ADENOSINE TRIPHOSPHATASE;

AQUEOUS HUMOR; ARTICLE; CELL VIABILITY; CELL VOLUME; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRABECULAR MESHWORK; ZYMOGRAPHY; CELL CULTURE; CELL LINE; CELL SIZE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SECRETION;

ACTINS; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; AQUEOUS HUMOR; CELL LINE, TRANSFORMED; CELL SIZE; CELL SURVIVAL; CELLS, CULTURED; CYTOCHALASIN D; CYTOSKELETON; DEXAMETHASONE; HUMANS; INTRAOCULAR PRESSURE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROSCOPY, CONFOCAL; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ADENOSINE A1; TRABECULAR MESHWORK;

EID: 83755166680     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8170     Document Type: Article

References (54)

1. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126(4):498-505.
2. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126(4):487-497.
3. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6): 701-713, discussion 829-730.
4. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 7: the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000; 130(4):429-440.
5. Tanihara H, Inatani M, Honjo M, et al. Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Arch Ophthalmol. 2008; 126(3):309-315.
6. Tian B, Geiger B, Epstein DL, Kaufman PL. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci. 2000;41(3):619-623.
7. Clark AF, Wilson K, McCartney MD, et al. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35(1): 281-294.
8. Clark AF, Brotchie D, Read AT, et al. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton. 2005; 60(2):83-95.
9. Clark AF, Wilson K, de Kater AW, Allingham RR, McCartney MD. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci. 1995;36(2):478-489.
10. Sanka K, Maddala R, Epstein DL, Rao PV. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2007;48(5):2105-2114.
11. Spiga MG, Borras T. Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma. Invest Ophthalmol Vis Sci. 2010;51(6):3029-3041.
12. el-Shabrawi Y, Eckhardt M, Berghold A, et al. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone. Eye. 2000;14(pt 3A):375-383.
13. Shearer TW, Crosson CE. Adenosine A1 receptor modulation of MMP-2 secretion by trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2002;43(9):3016-3020.
14. Tian B, Gabelt BT, Crosson CE, Kaufman PL. Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys. Exp Eye Res. 1997;64(6):979-989.
15. Crosson CE, Sloan CF, Yates PW. Modulation of conventional outflow facility by the adenosine A1 agonist N6-cyclohexyladenosine. Invest Ophthalmol Vis Sci. 2005;46(10):3795-3799.
16. Avila MY, Stone RA, Civan MM. A(1)-, A(2A)-and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse. Br J Pharmacol. 2001;134(2):241-245.
17. Crosson CE. Adenosine receptor activation modulates intraocular pressure in rabbits. J Pharmacol Exp Ther. 1995;273(1):320-326.
18. Crosson CE, Gray T. Characterization of ocular hypertension induced by adenosine agonists. Invest Ophthalmol Vis Sci. 1996; 37(9):1833-1839.
19. Husain S, Shearer TW, Crosson CE. Mechanisms linking adenosine A1 receptors and extracellular signal-regulated kinase 1/2 activation in human trabecular meshwork cells. J Pharmacol Exp Ther. 2007;320(1):258-265.
20. Li A, Leung CT, Peterson-Yantorno K, et al. Mechanisms of ATP release by human trabecular meshwork cells, the enabling step in purinergic regulation of aqueous humor outflow. J Cell Physiol. 2011 Mar 4. [Epub ahead of print]
21. Pang IH, Shade DL, Clark AF, Steely HT, DeSantis L. Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res. 1994;13(1):51-63.
22. Stamer WD, Seftor RE, Williams SK, Samaha HA, Snyder RW. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995;14(7):611-617.
23. Li A, Leung CT, Peterson-Yantorno K, Mitchell CH, Civan MM. Pathways for ATP release by bovine ciliary epithelial cells, the initial step in purinergic regulation of aqueous humor inflow. Am J Physiol Cell Physiol. 2010;299(6):C1308-C1317.
24. Tschumperlin DJ, Margulies SS. Equibiaxial deformation-induced injury of alveolar epithelial cells in vitro. Am J Physiol. 1998; 275(pt 1):L1173-L1183.
25. Yantorno RE, Coca-Prados M, Krupin T, Civan MM. Volume regulation of cultured, transformed, non-pigmented epithelial cells from human ciliary body. Exp Eye Res. 1989;49(3):423-437.
26. Hawkes SP, Li H, Taniguchi GT. Zymography and reverse zymography for detecting MMPs and TIMPs. Methods Mol Biol. 2010; 622:257-269.
27. Zhuo YH, He Y, Leung KW, et al. Dexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells. Mol Vis. 2010;16:61-71.
28. Fleischhauer JC, Mitchell CH, Stamer WD, et al. Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport. J Membr Biol. 2003;193(2):121-136.
29. Boudreault F, Grygorczyk R. Cell swelling-induced ATP release is tightly dependent on intracellular calcium elevations. J Physiol. 2004;561(pt 2):499-513.
30. Harteneck C, Reiter B. TRP channels activated by extracellular hypo-osmoticity in epithelia. Biochem Soc Trans. 2007;35(pt 1): 91-95.
31. Bao L, Locovei S, Dahl G. Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett. 2004;572(1-3):65-68.
32. Bao L, Sachs F, Dahl G. Connexins are mechanosensitive. Am J Physiol Cell Physiol. 2004;287(5):C1389-C1395.
33. Evans DW, Hosking SL, Embleton SJ, Morgan AJ, Bartlett JD. Spectral content of the intraocular pressure pulse wave: glaucoma patients versus normal subjects. Graefes Arch Clin Exp Ophthalmol. 2002;240(6):475-480.
34. Zhang X, Li A, Ge J, et al. Acute increase of intraocular pressure releases ATP into the anterior chamber. Exp Eye Res. 2007;85(5): 637-643.
35. Li A, Zhang X, Zheng D, Ge J, Laties AM, Mitchell CH. Sustained elevation of extracellular ATP in aqueous humor from humans with primary chronic angle-closure glaucoma. Exp Eye Res. 2011 Jul 2. [Epub ahead of print]
36. Wang J, Ma M, Locovei S, Keane RW, Dahl G. Modulation of membrane channel currents by gap junction protein mimetic peptides: size matters. Am J Physiol Cell Physiol. 2007;293(3): C1112-C119.
37. Silverman W, Locovei S, Dahl G. Probenecid, a gout remedy, inhibits pannexin 1 channels. Am J Physiol Cell Physiol. 2008; 295(3):C761-C767.
38. Bruzzone R, Barbe MT, Jakob NJ, Monyer H. Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem. 2005;92(5): 1033-1043.
39. Ma W, Hui H, Pelegrin P, Surprenant A. Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J Pharmacol Exp Ther. 2009;328(2):409-418.
40. Nishida M, Sato Y, Uemura A, et al. P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J. 2008;27(23):3104-3115.
41. Ebihara L, Liu X, Pal JD. Effect of external magnesium and calcium on human connexin46 hemichannels. Biophys J. 2003;84(1):277-286.
42. North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82(4):1013-1067.
43. Donnelly Roberts DL, Jarvis MF. Discovery of P2X7 receptorselective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br J Pharmacol. 2007;151(5):571-579.
44. Watanabe H, Takahashi R, Tran QK, et al. Increased cytosolic Ca(2+) concentration in endothelial cells by calmodulin antagonists. Biochem Biophys Res Commun. 1999;265(3):697-702.
45. Coco S, Calegari F, Pravettoni E, et al. Storage and release of ATP from astrocytes in culture. J Biol Chem. 2003;278:1354-1362.
46. Feranchak AP, Lewis MA, Kresge C, et al. Initiation of purinergic signaling by exocytosis of ATP-containing vesicles in liver epithelium. J Biol Chem. 2010;285:8138-8147.
47. Thyssen A, Hirnet D, Wolburg H, Schmalzing G, Deitmer JW, Lohr C. Ectopic vesicular neurotransmitter release along sensory axons mediates neurovascular coupling via glial calcium signaling. Proc Natl Acad Sci U S A. 2010;107:15258-15263.
48. Tokunaga A, Tsukimoto M, Harada H, Moriyama Y, Kojima S. Involvement of SLC17A9-dependent vesicular exocytosis in the mechanism of ATP release during T cell activation. J Biol Chem. 2010;285:17406-17416.
49. Luna C, Li G, Qiu J, Challa P, Epstein DL, Gonzalez P. Extracellular release of ATP mediated by cyclic mechanical stress leads to mobilization of AA in trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2009;50(12):5805-5810.
50. Cooper JA. Effects of cytochalasin and phalloidin on actin. J Cell Biol. 1987;105(4):1473-1478.
51. Filla MS, Schwinn MK, Nosie AK, Clark RW, Peters DM. Dexamethasone-associated cross-linked actin network formation in human trabecular meshwork cells involves beta3 integrin signaling. Invest Ophthalmol Vis Sci. 2011;52(6):2952-2959.
52. Kregenow FM. The response of duck erythrocytes to nonhemolytic hypotonic media: evidence for a volume-controlling mechanism. J Gen Physiol. 1971;58(4):372-395.
53. Hoffmann EK, Lambert IH, Pedersen SF. Physiology of cell volume regulation in vertebrates. Physiol Rev. 2009;89(1):193-277.
54. Yegutkin GG. Nucleotide-and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta. 2008;1783(5):673-694.